Centro de Investigación Curico

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis2 trials
• COPD1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Contineum Therapeutics1 trial
• Genentech, Inc.1 trial
• United Therapeutics1 trial

Running trials

• Recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

  NCT07284459· Phase 2· Contineum Therapeutics· Source

  Contact: Nikki Nepomuceno

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· United Therapeutics· Source

  Contact: Reinaldo Eduardo Cortez de la Fuente

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis2 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· Phase 2· Genentech, Inc.· Source